Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331]... von Okumu, Eunice Akinyi, Henderson, Gail E., Golin, Carol, Kuczynski, Kriste, Ormsby, Nuchanart Q., Peay, Holly L.

Volltext

HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption von Okumu, Eunice Akinyi, Henderson, Gail E., Golin, Carol, Kuczynski, Kriste, Ormsby, Nuchanart Q., Peay, Holly L.

Volltext

Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment von Henderson, Gail E, Peay, Holly L, Kroon, Eugene, Cadigan, Rosemary Jean, Meagher, Karen, Jupimai, Thidarat, Gilbertson, Adam, Fisher, Jill, Ormsby, Nuchanart Q, Chomchey, Nitiya, Phanuphak, Nittaya, Ananworanich, Jintanat, Rennie, Stuart

Volltext

Going off antiretroviral treatment in a closely monitored HIV “cure” trial: longitudinal assessments of acutely diagnosed trial participants and decliners von Henderson, Gail E, Waltz, Margaret, Meagher, Karen, Cadigan, R Jean, Jupimai, Thidarat, Isaacson, Sinéad, Ormsby, Nuchanart Q, Colby, Donn J, Kroon, Eugène, Phanuphak, Nittaya, Ananworanich, Jintanat, Peay, Holly L

Volltext

Recommendations from Thai stakeholders about protecting HIV remission (‘cure’) trial participants: report from a participatory workshop von Peay, Holly L, Ormsby, Nuchanart Q, Henderson, Gail E, Jupimai, Thidarat, Rennie, Stuart, Siripassorn, Krittaecho, Kanchawee, Kunakorn, Isaacson, Sinéad, Cadigan, R Jean, Kuczynski, Kriste, Likhitwonnawut, Udom

Volltext

Corrigendum to "HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption" J Virus Erad 9 (2) (June 2023) 100331 von Okumu, Eunice Akinyi, Henderson, Gail E, Golin, Carol, Kuczynski, Kriste, Ormsby, Nuchanart Q, Peay, Holly L

Volltext